Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serpin peptidase inhibitor, clade B (ovalbumin), member 6 (SERPINB6), also known as serpin B6 or PI-6, is an intracellular serine protease inhibitor belonging to the serpin superfamily, specifically the ovalbumin (clade B) family. SERPINB6 plays a protective role in specialized cells by preventing inappropriate proteolytic activity, especially by inhibiting serine proteases such as cathepsin G, kallikrein-8, and thrombin. In the inner ear, SERPINB6 protects sensory hair cells from stress-induced leakage of lysosomal proteases; loss-of-function mutations result in vulnerability to proteolytic injury, leading to sensorineural hearing loss (DFNB91). It is also involved in regulation of protease activity in mast cells and keratinocytes, contributing to immune and inflammatory responses. Altered expression is observed in colorectal cancer and during gonadal development. No approved drugs directly target SERPINB6; its primary significance is in genetic disease (DFNB91) and potential as a cancer biomarker.
Not established for drugs (most data relate to endogenous inhibitory mechanisms: inhibition of specific serine proteases)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serpin peptidase inhibitor, clade B (ovalbumin), member 6 (SERPINB6).